Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
Superinvestors holding AVIR, Q2 2026
No superinvestor reported holding AVIR in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of AVIR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q3 2021
1 superinvestor holding at quarter end